< Back to scientific publications

Magazine 11.50

Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations.

Authors: Lapenta L, Morano A, Casciato S, Fanella M, Fattouch J, Vaudano AE, Gregori B, Vanacore N, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2014

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2.07

ntimicrobial properties of platelet rich plasma

Authors: Ferraro A.S., Ronci C., Lanti A., Chiru O.M., Papa A., Insalaco D., Marconi G., Pattofatto ., Docimo F., DeMasi A., Marino D., Ippolito M., Cipriani C., Guiducci G., Adorno G.

Date: 2014

Scope of interest: Clinical pathology


Read details
Report/Poster of Convention/Congress Act

Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS-CoV-2 infection

Authors: Cristina D'Amico (1) - Federico De Angelis (1) - Elena Gigliotti (1) - Maria Trimboli (1) - Giorgia Guiducci (1) - Francesca Docimo (1) - Paolo Paesano (1) - Antonietta Arduini (1) - Francesca Chiarlitti (1) - Manuela Alo' (1) - Carla Gargiulo (1)

Date: 2022

Scope of interest: Clinical pathology


Read details
Magazine

AntiemeticProphylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to PreventChemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin’SLymphoma Naïve PatientsReceiving ABVD Regimen: A MulticenterPhaseIia Study

Authors: Daniela Nasso,Silvia Bolis, Elisabetta Abbruzzese, Ilaria Romano,Ida Provenzano Cristiano Tesei,Ida Provenzano, Maria Cantonetti

Date: 2020

Scope of interest: Haematology


Read details